Davis Polk & Wardwell represented Roivant Sciences, while Latham & Watkins represented the underwriters in the offering. Roivant Sciences (Nasdaq: ROIV) has announced its $230 million...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini advised Pacific Biosciences of California on the offering, and Davis Polk advised the representatives of the several underwriters involved. Pacific Biosciences of California Inc. announced...
You must be a Standard 1 Year member to access this content.
Davis Polk and Hogan Lovells advised Precigen on the offering, and Goodwin Procter advised the underwriters involved. Precigen Inc. announced the SEC-registered offering of an aggregate of...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Deciphera Pharmaceuticals, and Davis Polk advised the joint book-running managers involved in the offering. Deciphera Pharmaceuticals Inc. announced a $135.1 million SEC-registered common stock...
You must be a Standard 1 Year member to access this content.
Davis Polk advised Sun Pharmaceutical, and Goodwin Procter advised Concert Pharmaceuticals. Sun Pharmaceutical Industries Limited announced its acquisition of Concert Pharmaceuticals Inc., through a tender offer for an...
You must be a Standard 1 Year member to access this content.
Latham & Watkins LLP represented Terns Pharmaceuticals in the offering and Davis Polk advised the underwriters involved. Terns Pharmaceuticals, Inc. (Nasdaq: TERN), a clinical-stage biopharmaceutical company...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini and Latham & Watkins advised Prometheus Biosciences on the deal, while Davis Polk & Wardwell advised the representatives of the several underwriters. Prometheus Biosciences,...
You must be a Standard 1 Year member to access this content.
Skadden advised Trimble on the deal, while Latham & Watkins and Wardynski & Partners advised Hg. POELLATH advised the management of Transporeon. Davis Polk advised BofA...
You must be a Standard 1 Year member to access this content.
Sidley Austin advised Biodesix, while Davis Polk & Wardwell advised the underwriter William Blair in the offering. Biodesix, Inc. executed the offering of 35,075,000 shares (including the...
You must be a Standard 1 Year member to access this content.
Cooley advised RAPT Therapeutics, while Davis Polk advised the joint book-running managers in the offering. RAPT Therapeutics, Inc. executed a $75 million SEC-registered follow-on offering of 4,054,055...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the representatives of the underwriters in the offering. Brookdale Senior Living Inc. executed a $125 million SEC-registered offering of 2,500,000 tangible equity units. BofA...
You must be a Standard 1 Year member to access this content.
Cooley represented Zoetis, while Davis Polk advised the joint book-running managers in the offering. Zoetis Inc. executed its offering of $600 million aggregate principal amount of its...
You must be a Standard 1 Year member to access this content.
